InMed Conferences and Events
InMed’s CEO, Eric A. Adams, to Present Live at Life Sciences Investor Forum
Date: Thursday, June 24th
Time: 12:30PM ET
Available on demand: https://bit.ly/3xCTkfE
Presentation details: InMed invites individual and institutional investors, as well as advisors and analysts, to attend.
This will be a live, interactive online event where investors are invited to ask the company questions in real-time. If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available after the event.
It is recommended that investors pre-register and run the online system check to expedite participation and receive event updates.
Learn more about the event at www.lifesciencesinvestorforum.com.
InMed’s CEO, Eric A. Adams, to present at BIO Digital 2021
Date: June 10-11 and 14-18, 2021
InMed’s presentation will be available on demand to registered attendees during the conference, starting June 10th at 9am ET. InMed’s presentation can be accessed from the BIO Digital website at https://www.bio.org/events/bio-digital/sessions/800498.
To schedule 1×1 meetings with InMed, please do so through the BIO One on One Partnering System.
InMed Pharmaceuticals to Report Third Quarter Fiscal 2021 Financial Results
Date: May 13, 2021, 8:00am PT / 11:00am ET
Conference Call & Webcast*:
Thursday, May 13, 2021 at 8:00 AM Pacific Time, 11:00 AM Eastern Time
US/CANADA Participant Toll-Free Dial-In Number: +1 (855) 605-1745
US/CANADA Participant International Dial-In Number: +1 (914) 987-7959
Conference ID: 3186833
(*Webcast replay available for 90 days)
InMed to Present at Canaccord Genuity’s 5th Annual Global Cannabis Conference
Date: May 11, 2021, 2:30-2:55pm ET
Presentation Details: InMed’s President and CEO, Eric A. Adams, will be presenting at Canaccord Genuity’s 5th Annual Global Cannabis Conference, which will be held virtually this year.
To schedule a 1×1 meeting, please do so through the conference portal or reach out to [email protected]harma.com.
InMed Pharmaceuticals Webinar
Date: April 28, 2021, 11:00am ET
Presentation Details: In this live webinar, Eric Adams and Bruce Colwill will present an overview of the company’s recent operating and financial activities, followed by a Q&A session.
33rd Annual ROTH Conference
Date: March 15-17th
Presentation Details: Company CEO Eric A. Adams will participate in a Fireside Chat with ROTH analyst Scott Henry, CFA.
Fireside Chat Date/Time: Monday, March 15th at 4:30pm ET
Fireside Chat Link: https://wsw.com/webcast/roth35/inm/1678644
H. C. Wainwright Global Life Sciences Conference
Date: March 9-10th
Presentation Details: The company presentation will be available on demand beginning March 9th at 7am EST, and can be found at the below link. The presentation will be archived for 90 days following the conclusion of the event.
Presentation Link: https://journey.ct.events/view/d9d5aa94-1651-4380-9c75-b8bf018118e6
Edison Open House: Global Conference 2021
Date: January 26-28, 2021
Conference website: https://www.edisongroup.com/event/open-house-global-healthcare-2021/
Presentation details: InMed’s CEO Eric A. Adams to present Thursday, January 28th at 1:30pm GMT / 8:30am EST. Presentation information available here.
For 1×1 meetings, please reach out to Laine Yonker at [email protected].
Cannabinoid-Derived Pharmaceuticals Industry Review Summit Europe
Date: January 19-21, 2021
Conference website: https://cdp-europe.com/
Panel participation details:
InMed’s Michael Woudenberg – Vice President, Chemistry, Manufacturing & Controls, Karen Long – Senior Director, Drug Development, and Prof. Mauro Maccarrone PhD – Scientific Advisor to InMed will all be featured as expert speakers at the event.
Mr. Michael Woudenberg will participate on the panel discussion “Comparing Whole Plant & Synthetic Cannabinoids & Their Potential in Pharmaceuticals” on January 20, 2021 at 12:00pm GMT.
Ms. Karen Long will participate on the panel discussion “The Industry Approach to Gaining Drug Approval” on January 20, 2021 at 2:30pm GMT.
In addition, Prof. Mauro Maccarrone, a member of InMed’s Scientific Advisory Board, will speak in a lecture entitled “Plant-Derived & Endogenous Cannabinoids: Naturally Different”.
H. C. Wainwright BioConnect 2021
InMed CEO Eric A. Adams to present at H. C. Wainwright BioConnect 2021.
Date: January 11-14, 2021
Conference Website: www.hcwevents.com/bioconnect.
Presentation Details: The company presentation by Eric A. Adams, President and CEO of InMed, will be available on demand beginning January 11th at 6am EST and can be found at the below link. The presentation will be archived for 90 days following the conclusion of the event. Presentation Link: https://journey.ct.events/view/a48c3f9e-1802-4279-95ca-eff84fafe024